Mohamed Houta | Biology and Life Sciences | Best Researcher Award

Mohamed Houta | Biology and Life Sciences | Best Researcher Award

Mr Mohamed Houta, Beni Suef University, Egypt

Mohamed Houta appears to be a strong candidate for the Research for Best Researcher Award based on his extensive experience and contributions in the field of vaccinology, particularly related to poultry diseases

publication profile

google scholar

Solid Background in Immunology and Vaccinology

Mohamed has a robust foundation in immunology and vaccine research, which is evident from his current role as a Scientific Affairs Manager at Klybeck Life Sciences and his prior experience at MEVAC for Vaccines. His focus on inactivated and live poultry vaccines, conducting preclinical and clinical trials, and ensuring regulatory compliance underscores his deep expertise.

Significant Research Contributions

His publication record highlights his research impact. For example, his work on the Emergence, Evolution, and Spread of Infectious Bronchitis Virus Genotype GI-23 published in Archives of Virology and Phylodynamic and Recombination Analyses published in Animals demonstrate his ability to conduct significant and relevant research. These studies have contributed to a better understanding of avian diseases, which is critical for advancing vaccine development.

Leadership in R&D

As a Scientific Affairs Manager, Mohamed has demonstrated leadership in research and development, particularly in vaccine design and production, including the implementation of complex R&D projects and ensuring compliance with European and Saudi regulations. His involvement in reviewing and approving the development and validation of analytical methods and in vivo vaccine testing protocols indicates a strong leadership role in research.

Ongoing Academic Pursuits

Mohamed is also pursuing a PhD in Veterinary Sciences with a focus on poultry diseases at Beni Suef University and Padua University, which further strengthens his qualifications as a researcher committed to advancing knowledge in his field.

Global Perspective

His involvement in research and clinical trials across different countries and his multilingual abilities (Arabic, English, and Italian) add a global perspective to his work, which is valuable in the context of a global award.

Conclusion

Given Mohamed Houta’s extensive research contributions, leadership in R&D, and ongoing academic pursuits, he is a suitable candidate for the Research for Best Researcher Award. His work not only advances public health through vaccine development but also contributes significantly to the global understanding of avian diseases.

Publication top notes

The emergence, evolution and spread of infectious bronchitis virus genotype GI-23

Phylodynamic and recombination analyses of avian infectious bronchitis GI-23 reveal a widespread recombinant cluster and new among-countries linkages

COVID-19: Risk assessment and mitigation measures in healthcare and non-healthcare workplaces

Infection with Avian Coronaviruses: A recurring problem in turkeys

Dall’Est all’Ovest: ricostruzione filodinamica della storia della variante 2 del virus della bronchite infettiva aviare

 

 

Andrei Kozlov | Evolutionary Biology | Best Researcher Award

Andrei Kozlov | Evolutionary Biology | Best Researcher Award

Prof Andrei Kozlov, Vavilov Institute of General Genetics RAS, Russia

Prof. Andrei Kozlov is the Chief of the Lab of Gene Neofunctionalization at the Vavilov Institute of General Genetics RAS and the Director of The Biomedical Center in St. Petersburg, Russia. He also heads the Kozlov Laboratory of Theoretical Biology at Peter the Great St. Petersburg Polytechnic University. Born on May 22, 1950, in St. Petersburg, he earned his M.Sci. in Biochemistry from Leningrad State University and his Ph.D. from the Petrov Research Institute of Oncology. With extensive research in molecular virology and oncology, he has significantly contributed to HIV and cancer research. Prof. Kozlov is married with three children. 📚🔬👨‍👩‍👧‍👦

Publication profile

scopus

Education

In 1972, I earned my M.Sci. in Biochemistry from the Chair of Biochemistry at Leningrad State University, Leningrad, Russia. 🧬 From 1972 to 1975, I pursued my Ph.D. at the Petrov Research Institute of Oncology in St. Petersburg, Russia, focusing on the biochemistry of nucleic acids in both normal and malignant tissues. My Ph.D. thesis was titled “A comparative study of low molecular weight nuclear RNAs in normal and tumor tissues.” 📚 Between 1978 and 1979, I underwent postdoctoral research training in the Lab of Tumor Cell Biology under Dr. R. C. Gallo at the NCI, NIH, Bethesda, MD, USA, specializing in molecular oncovirology. 🔬

Experience

In 1981, I began my career as a Molecular Biology Lecturer at the prestigious Boarding School №45 for especially talented children, attached to St. Petersburg State University. From 1983 to 1987, I lectured on the Biochemistry of nucleic acids at the university’s Department of Biochemistry. I founded and served as Deputy Director of the MPH Program at St. Petersburg State University from 2005 to 2012, where I also lectured on HIV/AIDS Epidemiology & Prevention. Since 2012, I’ve been the Founder and Chief of the St. Petersburg Seminar on Molecular and Evolutionary Biology. Between 2018 and 2019, I was a Professor in the Department of Medical Physics at Peter the Great St. Petersburg Polytechnic University, and since 2019, I have served as a High School Professor at the Institute of Biomedical Systems and Biotechnology. 🌟📚

Honors

From 1992 to 2010, a Fellowship at the International Agency for Research on Cancer (IARC) was the foundation for many notable achievements. During this time, the annual international conference “AIDS, Cancer and Public Health” was established, and 19 conferences were chaired. Notable positions included advisory roles to the Russian parliament on HIV legislation (1994-1995), coordination of the Russian HIV Vaccine Project (1998-2002), and serving on various advisory boards. Numerous awards were received, such as the Russian National Chumakov Award (1999) and the Vernadsky Award (2005). The Vavilov Prize (2020) recognized contributions to cancer and HIV research. 🧬🏅🌍

Research focus

It seems you’re interested in the research focus of A.P. Kozlov. Based on the list of publications provided, Kozlov’s research primarily revolves around the evolutionary and developmental biology (evo-devo) of gene expression, the role of tumors in evolution, and the relationship between normal and tumor-like organs. Kozlov’s work integrates aspects of molecular evolution, gene expression patterns in cancer, and the emergence of novel cell types during evolution. Notably, Kozlov explores the theory of “carcino-evo-devo,” which posits a significant evolutionary role for hereditary tumors. This interdisciplinary approach spans genomics, oncology, and evolutionary biology, shedding light on the complexity of developmental processes and cancer evolution. 🧬🔬🦠📊

Publication top notes

Diagrams Describing the Evolution of Gene Expression, the Emergence of Novel Cell Types During Evolution, and Evo-devo

Carcino-Evo-Devo, A Theory of the Evolutionary Role of Hereditary Tumors

The Theory of Carcino-Evo-Devo and Its Non-Trivial Predictions

Mammalian tumor-like organs. 2. Mammalian adipose has many tumor features and obesity is a tumor-like process

Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development

Biological Computation and Compatibility Search in the Possibility Space as the Mechanism of Complexity Increase During Progressive Evolution

Erratum: Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans (Infectious Agents and Cancer (2019) 14 (46) DOI: 10.1186/s13027-019-0262-5)

Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans

Oncogenes, tumor suppressor and differentiation genes represent the oldest human gene classes and evolve concurrently

The increase of the magnitude of spontaneous viral blips in some participants of phase II clinical trial of therapeutic optimized HIV DNA vaccine candidate